Huahao Zhongtian Pharmaceutical-B (02563) announced interim results. Net loss of 265.96 million yuan narrowed by 50.8% year-on-year

Zhitongcaijing · 3d ago

According to the Zhitong Finance App, Huahao Zhongtian Pharmaceutical-B (02563) announced its 2026 interim results, with revenue of 36.635 million yuan, up 147.8% year on year; gross profit of 34.08 million yuan, up 147.9% year on year; net loss of 265.96 million yuan, narrowing by 50.8% year on year; loss per share of 0.07 yuan.

According to the announcement, the increase in revenue was mainly due to the continuous expansion of the market coverage of the product Youtidelong injection, which led to an increase in product sales.